<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33756110</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>184</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>The antigenic anatomy of SARS-CoV-2 receptor binding domain.</ArticleTitle><Pagination><StartPage>2183</StartPage><EndPage>2200.e22</EndPage><MedlinePgn>2183-2200.e22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2021.02.032</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(21)00221-X</ELocationID><Abstract><AbstractText>Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) recognizing the virus spike and focus mainly on 80 that bind the receptor binding domain (RBD). We devise a competition data-driven method to map RBD binding sites. We find that although antibody binding sites are widely dispersed, neutralizing antibody binding is focused, with nearly all highly inhibitory mAbs (IC<sub>50</sub>&#xa0;&lt; 0.1&#xa0;&#x3bc;g/mL) blocking receptor interaction, except for one that binds a unique epitope in the N-terminal domain. Many of these neutralizing mAbs use public V-genes and are close to germline. We dissect the structural basis of recognition for this large panel of antibodies through X-ray crystallography and cryoelectron microscopy of 19 Fab-antigen structures. We find novel binding modes for some potently inhibitory antibodies and demonstrate that strongly neutralizing mAbs protect, prophylactically or therapeutically, in animal models.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dejnirattisai</LastName><ForeName>Wanwisa</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Daming</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ginn</LastName><ForeName>Helen M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duyvesteyn</LastName><ForeName>Helen M E</ForeName><Initials>HME</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Supasa</LastName><ForeName>Piyada</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Case</LastName><ForeName>James Brett</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Medicine, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yuguang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Thomas S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mentzer</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford OX3 7FZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Beibei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paesen</LastName><ForeName>Guido C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slon-Campos</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Camacho</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kafai</LastName><ForeName>Natasha M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>Adam L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rita E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Medicine, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Baoling</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Craig</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Peter Medawar Building for Pathogen Research, Oxford OX1 3SY, UK; Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolton</LastName><ForeName>Jai</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fyfe</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Peter Medawar Building for Pathogen Research, Oxford OX1 3SY, UK; Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Sunetra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peter Medawar Building for Pathogen Research, Oxford OX1 3SY, UK; Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Tiong Kit</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilbert-Jaramillo</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Miles W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; National Infection Service, Public Health England (PHE), Porton Down, Salisbury SP4 0JG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skelly</LastName><ForeName>Donal</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dold</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yanchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Worthing Hospital, Worthing BN11 2DH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford OX3 7FZ, UK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pollard</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Department of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Julian C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klenerman</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Peter Medawar Building for Pathogen Research, Oxford OX1 3SY, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 9DU, UK; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temperton</LastName><ForeName>Nigel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Chatham ME4 4TB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>Neil G</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertram</LastName><ForeName>Felicity K R</ForeName><Initials>FKR</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siebert</LastName><ForeName>C Alistair</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clare</LastName><ForeName>Daniel K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howe</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radecke</LastName><ForeName>Julika</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Townsend</LastName><ForeName>Alain R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford OX3 7FZ, UK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kuan-Ying A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan; Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fry</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongkolsapaya</LastName><ForeName>Juthathip</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford OX3 7FZ, UK; Siriraj Center of Research Excellence in Dengue &amp; Emerging Pathogens, Dean Office for Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. Electronic address: jmongkol@well.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diamond</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, St. Louis, MO 63110 USA. Electronic address: mdiamond@wustl.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Jingshan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford OX3 7BN, UK. Electronic address: ren@strubi.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuart</LastName><ForeName>David I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford OX3 7BN, UK; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford OX3 7FZ, UK; Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot OX11 0DE, UK; Instruct-ERIC, Oxford House, Parkway Court, John Smith Drive, Oxford OX4 2JY, UK. Electronic address: dave@strubi.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Screaton</LastName><ForeName>Gavin R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: gavin.screaton@medsci.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI157155</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007172</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>109965/Z/15/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00008/11</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_17137</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L018942/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0600520</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1001046</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001666" MajorTopicYN="N">Binding Sites, Antibody</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003412" MajorTopicYN="N">Cricetulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronavirus, SARS-CoV-2, anti-RBD antibody, receptor binding domain, antibody, immune responses, virus structure</Keyword></KeywordList><CoiStatement>Declaration of interests M.S.D. is a consultant for Inbios, Vir Biotechnology, NGM Biopharmaceuticals, and Carnival Corporation and is on the Scientific Advisory Boards of Moderna and Immunome. The M.S.D. laboratory has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology, and Emergent BioSolutions. G.R.S. sits on the GSK Vaccines Scientific Advisory Board. A.J.P. is Chair of UK Department Health and Social Care&#x2019;s (DHSC) Joint Committee on Vaccination &amp; Immunisation (JCVI), but does not chair or participate in the JCVI COVID19 committee, and is a member of the WHO&#x2019;s SAGE. The views expressed in this article do not necessarily represent the views of DHSC, JCVI, NIHR, or WHO. The University of Oxford has entered into a partnership with AstraZeneca on coronavirus vaccine development. All other authors declare no competing financial interests. The University of Oxford has protected intellectual property disclosed in this publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33756110</ArticleId><ArticleId IdType="pmc">PMC7891125</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2021.02.032</ArticleId><ArticleId IdType="pii">S0092-8674(21)00221-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aricescu A.R., Lu W., Jones E.Y. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr Sect D Biol Crystallogr. 2006;62:1243&#x2013;1250.</Citation><ArticleIdList><ArticleId IdType="pubmed">17001101</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes C.O., West A.P., Jr., Huey-Tubman K.E., Hoffmann M.A.G., Sharaf N.G., Hoffman P.R., Koranda N., Gristick H.B., Gaebler C., Muecksch F. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. Cell. 2020;182:828&#x2013;842.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7311918</ArticleId><ArticleId IdType="pubmed">32645326</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum A., Fulton B.O., Wloga E., Copin R., Pascal K.E., Russo V., Giordano S., Lanza K., Negron N., Ni M. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science. 2020;369:1014&#x2013;1018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299283</ArticleId><ArticleId IdType="pubmed">32540904</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y., Zhang J., Xiao T., Peng H., Sterling S.M., Walsh R.M., Jr., Rawson S., Rits-Volloch S., Chen B. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586&#x2013;1592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7464562</ArticleId><ArticleId IdType="pubmed">32694201</ArticleId></ArticleIdList></Reference><Reference><Citation>Caly L., Druce J., Roberts J., Bond K., Tran T., Kostecki R., Yoga Y., Naughton W., Taiaroa G., Seemann T. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med. J. Aust. 2020;212:459&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228321</ArticleId><ArticleId IdType="pubmed">32237278</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrique L., Duyvesteyn H.M., Malinauskas T., Zhao Y., Ren J., Zhou D., Walter T.S., Radecke J., Huo J., Ruza R.R. The SARS-CoV-2 Spike harbours a lipid binding pocket which modulates stability of the prefusion trimer. bioRxiv. 2020 doi: 10.1101/2020.08.13.249177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.13.249177</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Liu W., Zhang Q., Xu K., Ye G., Wu W., Sun Z., Liu F., Wu K., Zhong B. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg. Microbes Infect. 2020;9:313&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7033720</ArticleId><ArticleId IdType="pubmed">32020836</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Pan Z., Yue S., Yu F., Zhang J., Yang Y., Li R., Liu B., Yang X., Gao L. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19. Signal Transduct. Target. Ther. 2020;5:180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7464057</ArticleId><ArticleId IdType="pubmed">32879307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi X., Yan R., Zhang J., Zhang G., Zhang Y., Hao M., Zhang Z., Fan P., Dong Y., Yang Y. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science. 2020;369:650&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319273</ArticleId><ArticleId IdType="pubmed">32571838</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark S.A., Clark L.E., Pan J., Coscia A., McKay L.G.A., Shankar S., Johnson R.I., Griffiths A., Abraham J. Molecular basis for a germline-biased neutralizing antibody response to SARS-CoV-2. bioRxiv. 2020 doi: 10.1101/2020.11.13.381533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.13.381533</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFrancesco L. COVID-19 antibodies on trial. Nat. Biotechnol. 2020;38:1242&#x2013;1252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7576980</ArticleId><ArticleId IdType="pubmed">33087898</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong J., Zost S.J., Greaney A.J., Starr T.N., Dingens A.S., Chen E.C., Chen R.E., Brett Case J., Sutton R.E., Gilchuk P. Genetic and structural basis for recognition of SARS-CoV-2 spike protein by 2 a two-antibody cocktail. bioRxiv. 2021 doi: 10.1101/2021.01.27.428529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.428529</ArticleId></ArticleIdList></Reference><Reference><Citation>Du S., Cao Y., Zhu Q., Yu P., Qi F., Wang G., Du X., Bao L., Deng W., Zhu H. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy. Cell. 2020;183:1013&#x2013;1023.e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489885</ArticleId><ArticleId IdType="pubmed">32970990</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004;60:2126&#x2013;2132.</Citation><ArticleIdList><ArticleId IdType="pubmed">15572765</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginn H.M. Pre-clustering data sets using cluster4x improves the signal-to-noise ratio of high-throughput crystallography drug-screening analysis. Acta Crystallogr. D Struct. Biol. 2020;76:1134&#x2013;1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604910</ArticleId><ArticleId IdType="pubmed">33135684</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan A.O., Case J.B., Winkler E.S., Thackray L.B., Kafai N.M., Bailey A.L., McCune B.T., Fox J.M., Chen R.E., Alsoussi W.B. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies. Cell. 2020:744&#x2013;753.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7284254</ArticleId><ArticleId IdType="pubmed">32553273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K.-Y.A., Tan T.K., Chen T.-H., Huang C.-G., Harvey R., Hussain S., Chen C.-P., Harding A., Gilbert-Jaramillo J., Liu X. Plasmablast-derived antibody response to acute SARS-CoV-2 infection in humans. bioRxiv. 2020 doi: 10.1101/2020.08.28.267526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.28.267526</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo J., Zhao Y., Ren J., Zhou D., Duyvesteyn H.M.E., Ginn H.M., Carrique L., Malinauskas T., Ruza R.R., Shah P.N.M. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Cell Host Microbe. 2020;28:445&#x2013;454.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303615</ArticleId><ArticleId IdType="pubmed">32585135</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurlburt N.K., Seydoux E., Wan Y.H., Edara V.V., Stuart A.B., Feng J., Suthar M.S., McGuire A.T., Stamatatos L., Pancera M. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation. Nat. Commun. 2020;11:5413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7591918</ArticleId><ArticleId IdType="pubmed">33110068</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaimes J.A., Andr&#xe9; N.M., Chappie J.S., Millet J.K., Whittaker G.R. Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop. J.&#xa0;Mol. Biol. 2020;432:3309&#x2013;3325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166309</ArticleId><ArticleId IdType="pubmed">32320687</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.A., Xie X., Kalveram B., Lokugamage K.G., Muruato A., Zou J., Zhang X., Juelich T., Smith J.K., Zhang L. Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis. bioRxiv. 2020 doi: 10.1101/2020.08.26.268854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.26.268854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju B., Zhang Q., Ge J., Wang R., Sun J., Ge X., Yu J., Shan S., Zhou B., Song S. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020;584:115&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">32454513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Z., Oton J., Qu K., Cortese M., Zila V., McKeane L., Nakane T., Zivanov J., Neufeldt C.J., Cerikan B. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 2020;588:498&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116492</ArticleId><ArticleId IdType="pubmed">32805734</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586:516&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">32967006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreye J., Reincke S.M., Kornau H.C., S&#xe1;nchez-Sendin E., Corman V.M., Liu H., Yuan M., Wu N.C., Zhu X., Lee C.D. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell. 2020;183:1058&#x2013;1069.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510528</ArticleId><ArticleId IdType="pubmed">33058755</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q., Zhang L., Wang X. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. Receptor recognition mechanisms of coronaviruses: a decade of structural studies. J.&#xa0;Virol. 2015;89:1954&#x2013;1964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338876</ArticleId><ArticleId IdType="pubmed">25428871</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebschner D., Afonine P.V., Baker M.L., Bunk&#xf3;czi G., Chen V.B., Croll T.I., Hintze B., Hung L.W., Jain S., McCoy A.J. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 2019;75:861&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778852</ArticleId><ArticleId IdType="pubmed">31588918</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Wang P., Nair M.S., Yu J., Rapp M., Wang Q., Luo Y., Chan J.F.W., Sahi V., Figueroa A. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020;584:450&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">32698192</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Z., Deng Y.Q., Ye Q., Cao L., Sun C.Y., Fan C., Huang W., Sun S., Sun Y., Zhu L. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science. 2020;369:1505&#x2013;1509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402622</ArticleId><ArticleId IdType="pubmed">32703908</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastronarde D.N. Automated electron microscope tomography using robust prediction of specimen movements. J.&#xa0;Struct. Biol. 2005;152:36&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">16182563</ArticleId></ArticleIdList></Reference><Reference><Citation>Matrosovich M., Matrosovich T., Carr J., Roberts N.A., Klenk H.D. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J.&#xa0;Virol. 2003;77:8418&#x2013;8425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165236</ArticleId><ArticleId IdType="pubmed">12857911</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray P.B., Jr., Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., Netland J., Jia H.P., Halabi C., Sigmund C.D. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J.&#xa0;Virol. 2007;81:813&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797474</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S., Sirohi D., Dowd K.A., Chen Z., Diamond M.S., Kuhn R.J., Pierson T.C. Enhancing dengue virus maturation using a stable furin over-expressing cell line. Virology. 2016;497:33&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5502530</ArticleId><ArticleId IdType="pubmed">27420797</ArticleId></ArticleIdList></Reference><Reference><Citation>Nettleship J.E., Ren J., Rahman N., Berrow N.S., Hatherley D., Barclay A.N., Owens R.J. A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells. Protein Expr Purif. 2008;62:83&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">18662785</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera--a visualization system for exploratory research and analysis. J.&#xa0;Comput. Chem. 2004;25:1605&#x2013;1612.</Citation><ArticleIdList><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccoli L., Park Y.J., Tortorici M.A., Czudnochowski N., Walls A.C., Beltramello M., Silacci-Fregni C., Pinto D., Rosen L.E., Bowen J.E. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology. Cell. 2020;183:1024&#x2013;1042.e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7494283</ArticleId><ArticleId IdType="pubmed">32991844</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto D., Park Y.J., Beltramello M., Walls A.C., Tortorici M.A., Bianchi S., Jaconi S., Culap K., Zatta F., De Marco A. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020;583:290&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">32422645</ArticleId></ArticleIdList></Reference><Reference><Citation>Punjani A., Rubinstein J.L., Fleet D.J., Brubaker M.A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods. 2017;14:290&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">28165473</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S., Jaiswar A., Sarkar R. Dynamic Asymmetry Exposes 2019-nCoV Prefusion Spike. J.&#xa0;Phys. Chem. Lett. 2020;11:7021&#x2013;7027.</Citation><ArticleIdList><ArticleId IdType="pubmed">32787330</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi R., Shan C., Duan X., Chen Z., Liu P., Song J., Song T., Bi X., Han C., Wu L. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020;584:120&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">32454512</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons G., Reeves J.D., Rennekamp A.J., Amberg S.M., Piefer A.J., Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA. 2004;101:4240&#x2013;4245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC384725</ArticleId><ArticleId IdType="pubmed">15010527</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian X., Li C., Huang A., Xia S., Lu S., Shi Z., Lu L., Jiang S., Yang Z., Wu Y., Ying T. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg. Microbes Infect. 2020;9:382&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7048180</ArticleId><ArticleId IdType="pubmed">32065055</ArticleId></ArticleIdList></Reference><Reference><Citation>Toelzer C., Gupta K., Yadav S.K.N., Borucu U., Davidson A.D., Kavanagh Williamson M., Shoemark D.K., Garzoni F., Staufer O., Milligan R. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science. 2020;370:725&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050947</ArticleId><ArticleId IdType="pubmed">32958580</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Bovenkamp F.S., Hafkenscheid L., Rispens T., Rombouts Y. The Emerging Importance of IgG Fab Glycosylation in Immunity. J.&#xa0;Immunol. Res. 2016;196:1435&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pubmed">26851295</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dorp L., Tan C.C.S., Lam S.D., Richard D., Owen C., Berchtold D., Orengo C., Balloux F. Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation. bioRxiv. 2020 doi: 10.1101/2020.11.16.384743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.16.384743</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A.C., Park Y.-J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181:281&#x2013;292.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter T.S., Diprose J., Brown J., Pickford M., Owens R.J., Stuart D.I., Harlos K. A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation. J.&#xa0;Appl. Crystallogr. 2003;36:308&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159505</ArticleId><ArticleId IdType="pubmed">15930615</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter T.S., Ren J., Tuthill T.J., Rowlands D.J., Stuart D.I., Fry E.E. A plate-based high-throughput assay for virus stability and vaccine formulation. J.&#xa0;Virol. Methods. 2012;185:166&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3470038</ArticleId><ArticleId IdType="pubmed">22744000</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E.S., Bailey A.L., Kafai N.M., Nair S., McCune B.T., Yu J., Fox J.M., Chen R.E., Earnest J.T., Keeler S.P. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 2020;21:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7578095</ArticleId><ArticleId IdType="pubmed">32839612</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter G. Xia2: An expert system for macromolecular crystallography data reduction. J.&#xa0;Appl. Crystallogr. 2010;43:186&#x2013;190.</Citation></Reference><Reference><Citation>Winter G., Waterman D.G., Parkhurst J.M., Brewster A.S., Gildea R.J., Gerstel M., Fuentes-Montero L., Vollmar M., Michels-Clark T., Young I.D. DIALS: implementation and evaluation of a new integration package. Acta Crystallogr. D Struct. Biol. 2018;74:85&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5947772</ArticleId><ArticleId IdType="pubmed">29533234</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.-L., Abiona O., Graham B.S., McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260&#x2013;1263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright A., Tao M.H., Kabat E.A., Morrison S.L. Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. EMBO J. 1991;10:2717&#x2013;2723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC452979</ArticleId><ArticleId IdType="pubmed">1717254</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrobel A.G., Benton D.J., Hussain S., Harvey R., Martin S.R., Roustan C., Rosenthal P.B., Skehel J.J., Gamblin S.J. Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein. Nat. Commun. 2020;11:5337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577971</ArticleId><ArticleId IdType="pubmed">33087721</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu N.C., Yuan M., Liu H., Lee C.D., Zhu X., Bangaru S., Torres J.L., Caniels T.G., Brouwer P.J.M., van Gils M.J. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Rep. 2020;33:108274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522650</ArticleId><ArticleId IdType="pubmed">33027617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Wang F., Shen C., Peng W., Li D., Zhao C., Li Z., Li S., Bi Y., Yang Y. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020;368:1274&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7223722</ArticleId><ArticleId IdType="pubmed">32404477</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X., Qu K., Ciazynska K.A., Hosmillo M., Carter A.P., Ebrahimi S., Ke Z., Scheres S.H.W., Bergamaschi L., Grice G.L., CITIID-NIHR COVID-19 BioResource Collaboration A thermostable, closed SARS-CoV-2 spike protein trimer. Nat. Struct. Mol. Biol. 2020;27:934&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116388</ArticleId><ArticleId IdType="pubmed">32737467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylera F., Harth S., Waldherr D., Frisch C., Knappik A. Off-rate screening for selection of high-affinity anti-drug antibodies. Anal. Biochem. 2013;441:208&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">23906643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y., Cao D., Zhang Y., Ma J., Qi J., Wang Q., Lu G., Wu Y., Yan J., Shi Y. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat. Commun. 2017;8:15092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5394239</ArticleId><ArticleId IdType="pubmed">28393837</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan M., Wu N.C., Zhu X., Lee C.D., So R.T.Y., Lv H., Mok C.K.P., Wilson I.A. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science. 2020;368:630&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164391</ArticleId><ArticleId IdType="pubmed">32245784</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan M., Liu H., Wu N.C., Lee C.D., Zhu X., Zhao F., Huang D., Yu W., Hua Y., Tien H. Structural basis of a shared antibody response to SARS-CoV-2. Science. 2020;369:1119&#x2013;1123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402627</ArticleId><ArticleId IdType="pubmed">32661058</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K. Gctf: Real-time CTF determination and correction. J.&#xa0;Struct. Biol. 2016;193:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4711343</ArticleId><ArticleId IdType="pubmed">26592709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Woen S., Wang T., Liau B., Zhao S., Chen C., Yang Y., Song Z., Wormald M.R., Yu C., Rudd P.M. Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs. Drug Discov. Today. 2016;21:740&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">26821133</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao G., Du L., Ma C., Li Y., Li L., Poon V.K., Wang L., Yu F., Zheng B.J., Jiang S., Zhou Y. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol. J. 2013;10:266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765664</ArticleId><ArticleId IdType="pubmed">23978242</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Ren J., Padilla-Parra S., Fry E.E., Stuart D.I. Lysosome sorting of &#x3b2;-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor. Nat. Commun. 2014;5:4321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4104448</ArticleId><ArticleId IdType="pubmed">25027712</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Duyvesteyn H.M.E., Chen C.P., Huang C.G., Chen T.H., Shih S.R., Lin Y.C., Cheng C.Y., Cheng S.H., Huang Y.C. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat. Struct. Mol. Biol. 2020;27:950&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pubmed">32737466</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov J., Nakane T., Forsberg B.O., Kimanius D., Hagen W.J.H., Lindahl E., Scheres S.H.W. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife. 2018;7:e42166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6250425</ArticleId><ArticleId IdType="pubmed">30412051</ArticleId></ArticleIdList></Reference><Reference><Citation>Zost S.J., Gilchuk P., Case J.B., Binshtein E., Chen R.E., Nkolola J.P., Sch&#xe4;fer A., Reidy J.X., Trivette A., Nargi R.S. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020;584:443&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584396</ArticleId><ArticleId IdType="pubmed">32668443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>